Prostatic acid phosphatase (PAP) was the seminal biomarker used in the diagnosis of prostate cancer several decades ago, but was eventually supplanted by PSA due to its poor sensitivity in PCa screening and inferiority as an indicator of PCa recurrence. Here, KLK3 is linked to prostate carcinoma.